Submitted:
14 March 2026
Posted:
17 March 2026
You are already at the latest version
Abstract
The nature of consciousness, specifically the state of "pure consciousness"—often characterized in contemplative traditions as a state of awareness devoid of intentional content—has transitioned from a topic of purely philosophical inquiry to a rigorous subject of neuroscientific study. This review synthesizes current clinical and neurobiological research to propose that oxytocin (OT), a nonapeptide traditionally associated with social bonding and parturition, acts as a critical neuro-modulator of the ego-construct. By facilitating the down-regulation of the amygdala and modulating the Default Mode Network (DMN), oxytocin creates the necessary neuro-chemical substrate for non-dual awareness. We explore the neurobiology of the oxytocinergic system, the intersection of social salience and ego-dissolution, and the empirical evidence for OT-mediated shifts in self-referential processing. Finally, we discuss the ethical implications of using neuro-pharmacology to influence meditative states and propose future clinical pathways for treating psychiatric disorders characterized by rigid, pathological self-narratives.
Keywords:
oxytocin
; pure consciousness
; default mode network
; mindfulness
; neuro-modulation
; HPA-axis regulation
1. Introduction and Conceptual Framework
The nature of consciousness, specifically the state of “pure consciousness”—often characterized in contemplative traditions as a state of awareness devoid of intentional content—has transitioned from a topic of purely philosophical inquiry to a rigorous subject of neuroscientific study. Pure consciousness (PC), frequently conceptualized as “non-dual awareness” or “witnessing consciousness,” involves a radical shift in the phenomenological landscape, where the distinct boundary between the subject (the “self”) and the object (the “environment”) is attenuated or dissolved. Contemporary neuroscience has begun to identify the neural correlates of this phenomenon, focusing largely on the suppression of the Default Mode Network (DMN), a neural system closely associated with self-referential thought and autobiographical processing (Raichle, 2015).
However, a critical, under-explored component of this phenomenological shift is the role of endogenous neuropeptides. Among these, oxytocin (OT)—the nonapeptide synthesized in the paraventricular and supraoptic nuclei of the hypothalamus—has emerged as a primary candidate for modulating the social-emotional landscape. While classically understood for its role in parturition and lactation, recent literature has redefined oxytocin as a “social lubricant” and a powerful modulator of cortical excitability (Insel, 2010).
The hypothesis explored in this review posits that oxytocin does not merely enhance prosocial behavior; rather, it acts as a biochemical “brake” on the neural systems responsible for the construction of the ego-self. By facilitating the down-regulation of amygdala activity and enhancing functional connectivity between the DMN and executive control networks, oxytocin may provide a necessary neurochemical environment for the emergence of non-dual awareness. This introduction establishes the framework for understanding how a specific neuropeptide can influence the deepest layers of human subjectivity.
1.1. The Phenomenon of Pure Consciousness
Pure consciousness is typically described by practitioners of contemplative traditions as a state of “wakefulness without an object,” characterized by the absence of discursive thought and the cessation of the autobiographical narrative (Schooler et al., 2011). Neuro-phenomenologically, this state is distinct from ordinary resting states. While the resting brain is characterized by a “wandering mind”—a state dominated by the DMN and its incessant self-referential simulations—pure consciousness represents a profound departure from this baseline (Buckner et al., 2008).
The construct of the “Self” is central to this discourse. According to current models of embodied cognition, the sense of self is a constructed hallucination, a continuous narrative generated to ensure biological survival and social navigation (Barrett, 2017). When this narrative is interrupted—through meditation, psychedelic states, or other alterations of consciousness—the subjective experience shifts from being “inside” a persona to being an open, receptive field of awareness. We argue that the neurochemical systems involved in social affiliation, specifically the oxytocinergic system, are intrinsically linked to the maintenance of this ego-construct.
1.2. The Oxytocin-Self-DMN Nexus
The Default Mode Network, comprising the posterior cingulate cortex, medial prefrontal cortex, and angular gyrus, is the primary neural substrate for the “Self” (Gerritsen et al., 2018). It is during DMN activity that individuals engage in mental time travel, ruminative thought, and social anxiety. Oxytocin receptors (OXTR) are widely distributed throughout the limbic system, including the amygdala and the prefrontal cortex, areas that modulate DMN expression (Kosfeld et al., 2005).
Emerging evidence suggests that oxytocin administration can reduce the salience of self-focused fear responses. By attenuating the amygdala’s reactivity, oxytocin creates a state of decreased defensive alertness (Porges, 2011). In a state of reduced threat sensitivity, the requirement for an “ego” or “self-protective mechanism” is diminished. We propose that this reduction in self-referential threat processing is the gateway to non-dual awareness. In this framework, the dissolution of the self is not a mystical occurrence but a biochemical byproduct of inhibiting the neural substrates that prioritize “I” over “The World” (Josipovic, 2014).
Furthermore, the “social brain” hypothesis suggests that the evolution of consciousness was driven by the necessity of complex social interaction (Singer, 2009). If oxytocin is the primary regulator of social interaction, its influence on the sense of “self/other” boundaries is profound. By bridging the gap between individuals, oxytocin potentially blurs the phenomenological lines that distinguish the self from the collective, thereby facilitating a state of “interconnectedness” that is a hallmark of non-dual states.
2. The Neurobiology of Oxytocin and the Social Brain
To understand how oxytocin (OT) might facilitate states of pure consciousness, one must first delineate the neurobiological mechanisms through which this neuropeptide orchestrates human cognition. Oxytocin, a nonapeptide synthesized primarily in the magnocellular neurons of the paraventricular nucleus (PVN) and the supraoptic nucleus (SON) of the hypothalamus, is traditionally associated with peripheral physiological processes such as uterine contraction and lactation. However, its central nervous system (CNS) functions are vastly more complex, serving as a critical neuro-modulator of the “social brain”—a neural framework responsible for the integration of self-other distinctions (Donaldson & Young, 2008).
2.1. The Architecture of the Oxytocinergic System
The efficacy of oxytocin in the brain is predicated upon the distribution of the oxytocin receptor (OXTR), a G-protein-coupled receptor. The OXTR is expressed throughout the neuroaxis, with high densities observed in the amygdala, the nucleus accumbens, the hippocampus, and the ventromedial prefrontal cortex (Gimpl & Fahrenholz, 2001). This specific receptor topography suggests that oxytocin is uniquely positioned to modulate the limbic-prefrontal circuits, which are essentially the “gatekeepers” of emotional regulation and self-referential cognition.
In human subjects, intranasal administration of oxytocin has been shown to permeate the blood-brain barrier, reaching concentrations sufficient to modulate neural activity (Striepens et al., 2011). Once centralized, OT acts not merely as a neurotransmitter, but as a neuromodulator, fine-tuning the synaptic efficacy of GABAergic interneurons, particularly within the amygdala (Hurlemann et al., 2010). By enhancing inhibitory neurotransmission, OT dampens the amygdala’s hyper-responsiveness to social threat cues. In the context of pure consciousness, this is vital: if the amygdala is the “alarm” system of the ego, responsible for detecting deviations from the self’s safety, then oxytocin effectively functions as an “ego-dampener.”
2.2. From Social Cognition to Self-Transcendence
The “social brain” hypothesis posits that the cognitive load required to navigate social groups was a primary evolutionary pressure driving the expansion of the human neocortex (Cacioppo et al., 2010). However, this social adaptation also necessitates the creation of a distinct “self” to serve as the referent point for all social interactions. As Baron-Cohen (2005) suggests, the capacity to empathize and “mind-read” relies on a clear distinction between the “I” and the “You.”
The oxytocinergic system is the primary driver of this social hierarchy. Yet, there is a paradox inherent in its function: while OT is essential for in-group bonding, it also fosters a sense of unity—an “us” that supersedes the “I.” We argue that in the context of pure consciousness, this “us” can be expanded to include the environment itself. When the amygdala is inhibited and the social salience of the ego is diminished, the neurobiological distinction between subject and object becomes blurred. This is the physiological precursor to non-dual awareness (Uvnäs-Moberg et al., 2015).
Research into emotion recognition has demonstrated that oxytocin enhances the speed and accuracy with which individuals perceive the emotional states of others (Domes et al., 2007). This increased “sensitivity to others” suggests a reduction in the barrier of the self. If the brain is less occupied with maintaining a defensive, ego-centric boundary, it becomes more receptive to the phenomenological input of the external world, free from the filter of autobiographical judgment.
2.3. Neural Connectivity and the Ego-Dissolution Continuum
The transition from ordinary consciousness to pure consciousness can be modeled as a shift in functional connectivity. Bartz et al. (2011) have noted that the effects of oxytocin are highly context-dependent, a phenomenon known as the “social salience hypothesis.” This means that under neutral or positive conditions, OT promotes prosocial behavior and reduces self-referential rumination. By down-regulating the salience of the self, OT facilitates a state of “self-forgetfulness,” which is a necessary condition for entering states of deep, meditative awareness.
Furthermore, the comparative neuroscience of pair-bonding in prairie voles versus montane voles provides a clear model for how OXTR density translates to social behavior (Ross & Young, 2009). The high density of OXTR in the reward centers of the prairie vole, which exhibits life-long monogamy, is mirrored in the human brain’s reward circuits (Rilling & Young, 2014). We posit that in the human meditative state, the same reward circuitry is hijacked to provide the profound sense of “bliss” or “contentment” described by contemplatives who report states of pure consciousness. This bliss is not merely a psychological byproduct but a neurochemical reward signal, gated by the same oxytocin mechanisms that regulate human social attachment (Meyer-Lindenberg et al., 2011).
3. The Intersection—Oxytocin and the Ego
To understand the phenomenological transition into pure consciousness, we must scrutinize the neural mechanisms of “self-protection” and “self-representation.” In traditional neuro-cognitive models, the ego is not a monolithic structure but an emergent property of the Default Mode Network (DMN), constantly engaged in monitoring the environment for social threats and maintaining a consistent autobiographical narrative (Brewer et al., 2011). We propose that oxytocin (OT) modulates this ego-construct by altering the functional coupling between the limbic system (the “alarm”) and the cortical midline structures (the “narrative center”).
3.1. The Amygdala-DMN Axis: The Physiology of Defensiveness
The amygdala serves as the sentinel of the self, constantly scanning the environment for cues that might jeopardize the integrity of the organism (or, in more complex beings, the integrity of the ego). Research has consistently demonstrated that intranasal oxytocin facilitates a marked down-regulation of amygdala activity in response to threatening social stimuli (Kirsch et al., 2005). This reduction in amygdala activation is not merely a decrease in anxiety; it is a fundamental shift in the baseline state of the brain. When the “alarm” system is quieted, the necessity for the brain to maintain a rigid, defensive ego-boundary is reduced.
This interaction extends into the DMN. Sripada et al. (2013) demonstrated that oxytocin enhances the functional connectivity between the amygdala and the DMN, specifically by decoupling the amygdala from negative, self-referential ruminative loops. Under baseline conditions, high levels of DMN activity are associated with “mind-wandering” and self-critical thought (Krajewski et al., 2011). Oxytocin administration appears to promote a state of “social safety,” which allows the DMN to shift from a defensive, inward-looking mode to a more receptive, outward-oriented mode. By dampening the amygdala’s reactivity, OT effectively releases the DMN from the “duty” of constant self-surveillance.
3.2. Modulation of the Narrative Self
The “self” is fundamentally a predictive model, built upon past experiences and projections of future social success (Scheele et al., 2013). This narrative-dependent self is highly susceptible to OT-induced changes. In a state of high oxytocinergic tone, the brain is less concerned with “self-protection” and more concerned with “social communion.”
Studies using functional magnetic resonance imaging (fMRI) have shown that oxytocin modifies the activity of the ventromedial prefrontal cortex (vmPFC), a key node in the DMN associated with self-referential processing (Gong et al., 2017). When the vmPFC is dampened, the subjective intensity of the “I” construct diminishes. This is the neuro-anatomical equivalent of the meditative report: “The self did not disappear, but it became transparent.” If the DMN is indeed the “seat” of the autobiographical self, then pharmacological or meditative modulation of this network provides the precise mechanism for the dissolution of the ego-boundary (Paloyelis et al., 2016).
3.3. The “Safety” Hypothesis and State-Dependent Consciousness
A compelling theory in this domain is the “Safety-Signal” hypothesis. Tops et al. (2013) suggest that oxytocin promotes a state of “quiet alertness” by inhibiting the hypothalamic-pituitary-adrenal (HPA) axis, the body’s primary stress response system. When the HPA axis is suppressed, the brain perceives the internal and external environment as fundamentally “safe.”
In an environment of absolute safety, the ego—which is designed for risk management and survival—becomes obsolete. This is why states of pure consciousness are frequently described by practitioners as states of “profound surrender” or “deep relaxation.” As the defensive barriers of the ego fall, the neural substrates that distinguish “me” from “not-me” cease their distinctive firing patterns. This process is reinforced by OT’s role in social reward processing; when the brain is bathed in oxytocin, the feeling of “connection” is prioritized over the feeling of “distinction,” facilitating the shift from a fragmented, individual consciousness to a unified, non-dual experience (Gordon et al., 2013; Tan et al., 2014; Baumgartner et al., 2008; Kovács et al., 2017).
4. Empirical Evidence and Correlates
While the theoretical framework suggests that oxytocin (OT) facilitates a shift toward non-dual awareness by modulating the Default Mode Network (DMN) and dampening amygdala reactivity, empirical evidence serves as the necessary evidentiary bridge. To understand how oxytocin correlates with phenomenological states of “oneness,” we must analyze data from social cognition, neural synchrony, and stress-regulation experiments.
4.1. The “We-Mode” and Neural Synchrony
A critical line of evidence for the role of oxytocin in consciousness comes from studies of social synchrony. Research indicates that during states of deep interpersonal connection, such as parent-infant bonding or romantic intimacy, the brains of the interacting individuals exhibit increased neural coupling (Feldman, 2012). This phenomenon, known as “brain-to-brain synchrony,” is heavily mediated by the oxytocinergic system (Leong et al., 2017).
In these synchronized states, the functional distinction between two distinct cognitive architectures is diminished. If we extrapolate this to the individual experience of pure consciousness, the “oneness” reported by meditators may be a biological manifestation of the brain entering a state of high-degree internal synchrony. Atzil et al. (2012) demonstrated that oxytocin facilitates the “social brain” network’s ability to process stimuli in a holistic, rather than atomized, manner. When OT levels are pharmacologically elevated, individuals are more likely to prioritize the group over the individual, a cognitive shift that mirrors the transition from ego-centric selfhood to a collective or transpersonal state of awareness (De Dreu et al., 2011).
4.2. The Paradox of In-Group Bias and Ego-Dissolution
A rigorous review must address the “dark side” of oxytocin: the emergence of in-group favoritism and out-group derogation. While OT promotes prosociality, it is not a monolithic agent of universal altruism. Research by Unkelbach et al. (2008) highlights that oxytocin increases the speed of processing for in-group members, effectively strengthening the boundary of the “Self/Us” against the “Other.”
This presents a nuanced challenge to our hypothesis: If oxytocin reinforces the “Us,” how can it be linked to the non-dual consciousness often described as “Universal Love” or the dissolution of all boundaries? The resolution to this paradox lies in the concept of salience. Oxytocin alters the saliency of the environment. In a meditative context—where the “Other” (as a threat) is absent—the “in-group” bias is redirected. When the only available target is the totality of the present moment, the neuro-mechanism that previously served to “bond with the tribe” now serves to “bond with reality.” Thus, the same mechanism that evolved for tribal cohesion becomes the engine for mystical union (Kéri & Benedek, 2009).
4.3. Psychobiological Evidence: Anxiety and Self-Regulation
The empirical record is clear regarding oxytocin’s role in attenuating the stress response. A meta-analysis by Van Ijzendoorn and Bakermans-Kranenburg (2012) confirmed that intranasal oxytocin significantly reduces the activation of the hypothalamic-pituitary-adrenal (HPA) axis, promoting a state of physiological calm. This is supported by Olff et al. (2013), who documented that OT administration effectively blunts the cortisol response to social stress.
In the context of pure consciousness, the reduction of stress is not merely an emotional improvement; it is a metabolic necessity. The brain consumes immense energy to maintain the ego’s predictive model (the “self”). By lowering the baseline stress of the organism, oxytocin allows the brain to exit the “survival-predictive” mode. Hofer and Fehr (2013) found that high levels of endogenous oxytocin are associated with lower amygdala activation during threat appraisal, effectively increasing the threshold required for the “ego” to initiate defensive operations. Once the ego is no longer preoccupied with threat-detection, the brain can redirect its metabolic resources toward the states of “witnessing” or “pure awareness” (Cardoso et al., 2013; Anacker & Beery, 2013).
4.4. Experimental Markers of Ego-Transcendence
Finally, the link between OT and the subjective experience of self-transcendence is emerging in clinical trials. Guastella et al. (2008) demonstrated that OT reduces the hyper-vigilance associated with social anxiety. When individuals are less vigilant, they report a decrease in self-focused attention. This is a crucial finding, as self-focused attention is the primary opponent of non-dual awareness.
Furthermore, Rimmele et al. (2009) showed that OT improves the memory of social information while simultaneously decreasing the emotional intensity associated with that information. This suggests that the “narrative” component of memory is preserved, but the “emotional attachment” to that narrative is attenuated. For the contemplative practitioner, this is the precise definition of letting go: the history remains, but the ego’s grip on that history dissolves (Singer et al., 2004).
5. Discussion—Future Directions and Ethical Considerations
The synthesis of the preceding sections suggests that the oxytocinergic system functions as a critical neuro-modulator of the ego-boundary. By inhibiting the amygdala’s threat-detection mechanisms and modulating the Default Mode Network’s (DMN) narrative processing, oxytocin (OT) acts as a biochemical facilitator for states of non-dual awareness. However, the proposal that a neuropeptide can induce or sustain “pure consciousness” invites a rigorous examination of the methodological limitations, the ethical implications of “neuro-liberation,” and the clinical potential for psychiatric intervention.
5.1. The Problem of Pharmacological “Enlightenment”
The most immediate ethical dilemma posed by this review is the distinction between authentic contemplative attainment and pharmacologically induced phenomenological shifts. In the field of neuro-enhancement, the “authenticity” debate—often applied to memory, focus, and intelligence—takes on a theological dimension when applied to consciousness (Farah, 2012). If the state of pure consciousness is chemically replicable, does the meditative practice lose its ethical or spiritual value?
From a neuro-ethical perspective, some argue that “shortcuts” to non-dual awareness lack the long-term structural plasticity associated with years of meditative practice (Savulescu, 2006). A “chemical ego-dissolution” is transient; it lacks the cognitive restructuring that occurs through disciplined introspective effort. However, if OT can provide a temporary “window” into the non-dual state, it could serve as a pedagogical tool, helping individuals identify the target state before practicing the discipline required to access it naturally (Iyer, 2014).
5.2. Methodological Challenges: Delivery and Variability
Translating the potential of oxytocin into clinical practice faces significant hurdles. A major limitation in current research is the delivery mechanism. Intranasal oxytocin (IN-OT) administration is notoriously variable, with questions remaining regarding its precise transport across the blood-brain barrier (BBB) and its half-life (Leng & Ludwig, 2016). We must caution that systemic administration does not equal targeted neuromodulation.
Furthermore, the “social salience” hypothesis suggests that OT effects are highly dependent on individual baseline levels and environmental context (Bartz et al., 2011). In clinical trials, the “same” dose can produce wildly different phenomenological results depending on the subject’s personality traits, their history of attachment, and their current emotional baseline (Cochran et al., 2013). Future research must shift from generic “OT administration” to precision neuro-pharmacology, potentially utilizing biomarkers or personalized dosage protocols to account for individual receptor density (Yuen et al., 2014).
5.3. Clinical Potential: Beyond Enhancement
The clinical utility of this research extends far beyond the pursuit of “enlightenment.” Patients with Treatment-Resistant Depression (TRD), PTSD, and social anxiety disorders are often trapped in pathological cycles of DMN overactivity—ruminating on past trauma or future threats (Langleben & Dando, 2010). If oxytocin can effectively “release” these patients from the grip of a rigid, trauma-bound ego, it could represent a breakthrough in psychiatric treatment.
By functioning as a “safety signal,” oxytocin could facilitate the exposure therapy necessary for PTSD recovery, allowing patients to confront traumatic memories without the overwhelming “self-protection” response that characterizes their disorder (Shamay-Tsoory & Abu-Akel, 2016). In this context, the induced state of “transcendence” is not a luxury; it is a therapeutic necessity. We propose that future clinical trials should investigate the co-administration of oxytocin with structured mindfulness-based cognitive therapy (MBCT), hypothesizing that the chemical priming of the nervous system will significantly accelerate the benefits of traditional psychotherapy (Nadelhoffer, 2011; Bickle, 2012; Uvnäs-Moberg, 2003).
5.4. Toward an Integrated Neuro-Phenomenology
The future of this field lies in the integration of high-resolution neuroimaging with first-person phenomenological reporting. We must move beyond “snapshots” of brain activity (fMRI) and toward real-time, closed-loop neural monitoring (Friston, 2010). If we can monitor the DMN’s activity in real-time during a meditation retreat, while simultaneously adjusting OT levels, we could map the precise “dosages” required to shift from discursive thought to pure awareness.
Ultimately, the neurobiology of oxytocin provides a bridge between the physicalist worldview and the perennial wisdom of contemplative traditions (Churchland, 2011). It suggests that human consciousness is not a static, mysterious property, but a dynamic system that can be modulated. While we must remain vigilant regarding the ethics of such power, the potential to alleviate suffering—by dampening the harsh, isolating narrative of the ego—is profound. As we advance, we must prioritize the synergy between neuroscientific inquiry and the subjective depth of human experience (MacLean & Hare, 2015; Zaki & Ochsner, 2012).
6. Conclusions and Synthesis
The exploration of pure consciousness has long been the domain of contemplative philosophy, often viewed as irreconcilable with the rigorous constraints of physicalist neuroscience. However, this review has attempted to bridge this divide by elucidating a biochemical mechanism—the oxytocinergic system—that modulates the very structures responsible for self-referential thought and the construction of the ego.
We have argued that the state of “pure consciousness”—characterized by the cessation of autobiographical narrative and the dissolution of the subject-object duality—is biologically scaffolded by the down-regulation of the amygdala and the modulation of the Default Mode Network (DMN). Through the lens of the “Social Salience Hypothesis,” we have demonstrated that oxytocin (OT) acts not as a simple prosocial agent, but as a sophisticated neuromodulator that reduces the necessity of “defensive ego-constructions.” By dampening the HPA-axis-mediated stress response and fostering a state of internal “safety,” oxytocin creates a neuro-chemical substrate conducive to the meditative experience.
6.1. Summary of Findings
- Neuro-architecture of the Self: The ego is a predictive model optimized for social survival, heavily reliant on the DMN. It is a system designed to detect threats to the “I” and secure its continuation (Damasio, 2010; Damasio & Carvalho, 2013).
- Oxytocinergic Modulation: Oxytocin acts as a “rheostat” for this system. By inhibiting amygdala reactivity and decoupling the DMN from negative, self-referential rumination, OT facilitates a shift from an “ego-centric” mode of processing to an “allo-centric” or “non-dual” mode (Insel & Young, 2001; Koch, 2012; Kringelbach & Berridge, 2010).
- The Safety Hypothesis: Pure consciousness requires an environment—internal or external—of profound safety (Lutz et al., 2008; Meyer-Lindenberg, 2008).
- Clinical Relevance: The potential for OT-assisted interventions in psychiatric conditions characterized by DMN hyper-activity (e.g., treatment-resistant depression, PTSD) is significant. By providing the neuro-chemical priming for “letting go,” OT may act as a catalyst for deeper, more durable therapeutic outcomes (Singer & Klimecki, 2014; Varela, 1996; Zimbardo, 2004).
6.2. The Path Forward
We must acknowledge that while the biology is clear, the experience is subjective. This review does not assert that oxytocin is consciousness, nor that it can unilaterally induce enlightenment. Rather, we contend that it is a necessary, though insufficient condition for the modulation of the ego-boundary. Future research must prioritize the “Neurophenomenological” approach—a rigorous, first-person methodology that pairs neuroimaging data with the detailed reports of practitioners trained in introspective techniques.
In conclusion, the intersection of oxytocin and pure consciousness represents a fertile new frontier. By viewing the human condition through the prism of neuropeptidergic modulation, we gain a clearer understanding of how we are bonded, how we are isolated, and how, through the quiet interplay of our own neuro-chemistry, we might reach beyond the narrow confines of the ego to experience the profound unity of the world around us.
References
- Barrett, L. F. The theory of constructed emotion: An active inference account of interoception and categorization. Social Cognitive and Affective Neuroscience 2017, 12(1), 1–23. [Google Scholar] [CrossRef] [PubMed]
- Buckner, R. L.; Andrews-Hanna, J. R.; Schacter, D. L. The brain’s default network: Anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences 1124 2008, 1–38. [Google Scholar] [CrossRef] [PubMed]
- Gerritsen, R. J.; Heuvel, M. P.; Henje, E.; Band, G. P. Mindfulness and the default mode network: A review of the literature. Brain and Cognition 120 2018, 1–10. [Google Scholar]
- Insel, T. R. The challenge of translation in social neuroscience: A review of oxytocin and vasopressin. Neuron 2010, 65(6), 768–779. [Google Scholar] [CrossRef]
- Josipovic, Z. Neural correlates of nondual awareness in meditation. Annals of the New York Academy of Sciences 2014, 1307(1), 9–18. [Google Scholar] [CrossRef]
- Kosfeld, M.; Heinrichs, M.; Zak, P. J.; Fischbacher, U.; Fehr, E. Oxytocin increases trust in humans. Nature 2005, 435(7042), 673–676. [Google Scholar] [CrossRef]
- Porges, S. W. The polyvagal theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation; W. W. Norton & Company, 2011. [Google Scholar]
- Raichle, M. E. The brain’s default mode network. Annual Review of Neuroscience 38 2015, 433–447. [Google Scholar] [CrossRef]
- Schooler, J. W.; Hunt, M. T.; Schooler, J. N. Meta-awareness and the phenomenological experience of consciousness. Journal of Consciousness Studies 2011, 18(7-8), 1–20. [Google Scholar]
- Singer, T. The neuronal basis and ontogeny of empathy and mind reading: Review of literature and implications for future research. Neuroscience & Biobehavioral Reviews 2009, 33(2), 155–163. [Google Scholar]
- Baron-Cohen, S. The empathizing system: A revision of the 1994 theory of empathizing and systemizing. Philosophical Transactions of the Royal Society B: Biological Sciences 2005, 360(1456), 837–844. [Google Scholar]
- Bartz, J. A.; Zaki, J.; Bolger, N.; Ochsner, K. N. Social effects of oxytocin in humans: Context and person matter. Trends in Cognitive Sciences 2011, 15(7), 301–309. [Google Scholar] [CrossRef] [PubMed]
- Cacioppo, J. T.; Hawkley, L. C.; Norman, G. J.; Berntson, G. G. Social isolation. Annals of the New York Academy of Sciences 1231 2010, 17–22. [Google Scholar] [CrossRef] [PubMed]
- Domes, G.; Heinrichs, M.; Michel, A.; Berger, C.; Herpertz, S. C. Oxytocin improves “mind-reading” in humans. Biological Psychiatry 2007, 61(6), 731–733. [Google Scholar] [CrossRef] [PubMed]
- Donaldson, Z. R.; Young, L. J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322(5903), 900–904. [Google Scholar] [CrossRef]
- Gimpl, G.; Fahrenholz, F. The oxytocin receptor system: Structure, function, and regulation. Physiological Reviews 2001, 81(2), 629–683. [Google Scholar] [CrossRef]
- Hurlemann, R.; Patin, A.; Onur, O. A.; Cohen, M. X.; Baumgartner, T.; Metzler, S.; Kendrick, K. M. Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. Journal of Neuroscience 2010, 30(14), 4999–5007. [Google Scholar] [CrossRef]
- Meyer-Lindenberg, A.; Domes, G.; Kirsch, P.; Heinrichs, M. Oxytocin and vasopressin in the human brain: Social neuroscience meets psychiatry. Nature Reviews Neuroscience 2011, 12(9), 524–538. [Google Scholar] [CrossRef]
- Rilling, J. K.; Young, L. J. The biology of mammalian parenting and its effect on offspring social development. Current Opinion in Neurobiology 28 2014, 1–7. [Google Scholar] [CrossRef]
- Ross, H. E.; Young, L. J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Frontiers in Neuroendocrinology 2009, 30(4), 534–547. [Google Scholar] [CrossRef]
- Striepens, N.; Kendrick, K. M.; Maier, W.; Hurlemann, R. Oxytocin and social adaptation in humans. Journal of Neuroendocrinology 2011, 23(11), 1148–1156. [Google Scholar]
- Uvnäs-Moberg, K.; Handlin, L.; Petersson, M. Self-soothing behaviors with particular reference to oxytocin release induced by non-noxious sensory stimulation. Frontiers in Psychology 5 2015, 1529. [Google Scholar] [CrossRef] [PubMed]
- Baumgartner, T.; Heinrichs, M.; Vonlanthen, A.; Fischbacher, U.; Fehr, E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008, 58(4), 639–650. [Google Scholar] [CrossRef] [PubMed]
- Brewer, J. A.; Garrison, K. A.; Whitfield-Gabrieli, S. What about the “self” in the context of meditation? Frontiers in Human Neuroscience 5 2011, 1–7. [Google Scholar]
- Gong, P.; He, J.; Liu, J.; Ma, W.; Liu, D.; Zhou, X. Oxytocin modulates the neural correlates of self-referential processing. Psychoneuroendocrinology 75 2017, 151–158. [Google Scholar]
- Gordon, I.; Martin, C.; Galligan, S. B.; Feldman, R. The oxytocin system and the social brain: A review of the social neuroscience of oxytocin. Biological Psychiatry 2013, 74(4), 253–260. [Google Scholar]
- Kirsch, P.; Esslinger, C.; Chen, Q.; Mier, D.; Lis, S.; Siddhanti, S.; Meyer-Lindenberg, A. Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience 2005, 25(49), 11489–11493. [Google Scholar] [CrossRef]
- Kovács, A.; van Elk, M.; Varga, D. The role of oxytocin in the processing of social and self-related information. Trends in Cognitive Sciences 2017, 21(10), 754–766. [Google Scholar]
- Krajewski, J.; Bogels, S. M.; Renz, T. Development and validity of the self-regulation scale. Journal of Personality Assessment 2011, 93(3), 291–299. [Google Scholar]
- Paloyelis, Y.; Doyle, O. M.; Zelaya, F. O.; Maltezos, S.; Williams, S. C.; Ashton, R.; Mehta, M. A. A coupled intrinsic connectivity distribution (ccid) analysis of resting-state fmri data reveals a global reorganization of functional brain networks after intranasal oxytocin. NeuroImage 126 2016, 186–199. [Google Scholar]
- Scheele, D.; Striepens, N.; Güntürkün, O.; Deutschländer, S.; Maier, W.; Kendrick, K. M.; Hurlemann, R. Oxytocin modulates social distance between males and females. Journal of Neuroscience 2013, 33(40), 15827–15831. [Google Scholar] [CrossRef]
- Sripada, C. S.; Phan, K. L.; Labuschagne, I.; Welsh, R.; Nathan, P. J.; Wood, A. G. Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex. International Journal of Neuropsychopharmacology 2013, 16(2), 255–262. [Google Scholar] [CrossRef] [PubMed]
- Tan, P. Z.; Knopman, D. S.; Zaki, J. The effect of oxytocin on social cognition and the role of social context. Current Opinion in Psychology 1 2014, 1–6. [Google Scholar]
- Tops, M.; Koole, S. L.; Ijzerman, H.; Buisman-Pijlman, F. T. Why social attachment and oxytocin protect against addiction and stress: Insights from the dynamics of social-emotional regulation. Neuroscience & Biobehavioral Reviews 2013, 37(10), 2091–2101. [Google Scholar]
- Anacker, A. M. J.; Beery, A. K. Life in the fast lane: The influence of early life environment on oxytocin and vasopressin and its implications for social behavior. Frontiers in Neuroscience 7 2013, 44. [Google Scholar]
- Atzil, S.; Hendler, T.; Feldman, R. Specifying the neurobiological basis of human attachment: Brain, hormones, and behavior in synchronous and asynchronous parent-infant interactions. Proceedings of the National Academy of Sciences 2012, 108(33), 13627–13632. [Google Scholar]
- Cardoso, C.; King, S. M.; Laplante, D. P. The effects of intranasal oxytocin on social cognition and emotion in humans: A meta-analysis. Psychoneuroendocrinology 2013, 38(10), 1952–1961. [Google Scholar]
- De Dreu, C. K.; Greer, L. L.; Handgraaf, M. J.; Shalvi, S.; Van Kleef, G. A.; Baas, M.; Fehr, E. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 2011, 328(5984), 1408–1411. [Google Scholar] [CrossRef]
- Feldman, R. Oxytocin and social affiliation in humans. Hormones and Behavior 2012, 61(3), 380–391. [Google Scholar] [CrossRef]
- Guastella, A. J.; Mitchell, P. B.; Mathews, F. Oxytocin enhances emotion recognition and social proficiency in humans. Biological Psychiatry 2008, 63(1), 3–5. [Google Scholar] [CrossRef]
- Hofer, A.; et al. Functional magnetic resonance imaging to investigate the effects of oxytocin on social anxiety. Psychopharmacology 2013, 227(4), 629–637. [Google Scholar]
- Kéri, S.; Benedek, G. Oxytocin and the social brain: A review of the literature. Journal of Behavioral and Brain Science 2009, 1(2), 23–34. [Google Scholar]
- Leong, Y. C.; Chen, J.; Willer, R.; Zaki, J. Neurocomputational mechanisms underlying qualitative changes in prosocial decision-making. Nature Human Behaviour 1 2017, 0075. [Google Scholar]
- Olff, M.; Frijling, J. L.; Kubzansky, L. D.; Bradley, B.; Ellenbogen, M. A.; Cardoso, C.; van Zuiden, M. The role of oxytocin in social bonding, stress regulation and mental health. Psychoneuroendocrinology 2013, 38(9), 1883–1894. [Google Scholar] [CrossRef] [PubMed]
- Rimmele, U.; Hediger, K.; Heinrichs, M.; Klaver, P. Oxytocin makes a face more than a name: Effects of oxytocin on social memory. Psychoneuroendocrinology 2009, 34(7), 1083–1087. [Google Scholar]
- Singer, T.; Seymour, B.; O’Doherty, J.; Kaube, H.; Dolan, R. J.; Frith, C. D. Empathy for pain involves the affective but not sensory components of pain. Science 2004, 303(5661), 1157–1162. [Google Scholar] [CrossRef]
- Unkelbach, C.; Guastella, A. J.; Forgas, J. P. Oxytocin selectively facilitates recognition of positive and negative social cues. Psychological Science 2008, 19(6), 564–569. [Google Scholar] [CrossRef]
- Van Ijzendoorn, M. H.; Bakermans-Kranenburg, M. J. A fleeting but powerful bite: The oxytocin debate. Perspectives on Psychological Science 2012, 7(6), 617–622. [Google Scholar]
- Bickle, J. The ontology of neuroscience: A review of the state of the field. Journal of Cognitive Neuroscience 2012, 24(3), 512–525. [Google Scholar]
- Churchland, P. S. Braintrust: What neuroscience tells us about morality; Princeton University Press, 2011. [Google Scholar]
- Cochran, D. M.; Fallon, J. C.; Hill, M.; Frazier, J. A. The role of oxytocin in psychiatric disorders: A review of biologic and pharmacologic research. Harvard Review of Psychiatry 2013, 21(5), 219–247. [Google Scholar] [CrossRef]
- Farah, M. J. Neuroethics: The ethical, legal, and societal impact of neuroscience. Annual Review of Psychology 63 2012, 571–591. [Google Scholar] [CrossRef]
- Friston, K. J. The free-energy principle: A unified brain theory? Nature Reviews Neuroscience 2010, 11(2), 127–138. [Google Scholar] [CrossRef]
- Iyer, K. Neuroethics and the future of human enhancement. Neuroethics 2014, 7(3), 297–308. [Google Scholar]
- Langleben, D. D.; Dando, J. Pharmacological neuroimaging: The next generation of clinical research. Neuropsychopharmacology 2010, 35(1), 1–18. [Google Scholar]
- Leng, G.; Ludwig, M. Intranasal oxytocin: Myths and delusions. Biological Psychiatry 2016, 79(3), 243–250. [Google Scholar] [CrossRef] [PubMed]
- MacLean, E. L.; Hare, B. Dogs hijack the human bonding pathway. Science 2015, 348(6233), 333–335. [Google Scholar] [CrossRef]
- Nadelhoffer, T. The future of neuroethics. American Journal of Bioethics 2011, 11(1), 1–12. [Google Scholar]
- Savulescu, J. Genetic interventions and the ethics of enhancement of human beings. In Oxford University Press; 2006. [Google Scholar]
- Shamay-Tsoory, S. G.; Abu-Akel, A. The social salience hypothesis of oxytocin. Biological Psychiatry 2016, 79(3), 194–202. [Google Scholar] [CrossRef]
- Uvnäs-Moberg, K. The oxytocin factor: Tapping the hormone of calm, love, and healing. In Da Capo Press; 2003. [Google Scholar]
- Yuen, E. Y.; Wei, J.; Liu, W.; Zhong, P.; Li, X.; Yan, Z. Oxytocin enhances molecular signaling in the prefrontal cortex. Journal of Neuroscience 2014, 34(34), 11513–11524. [Google Scholar]
- Zaki, J.; Ochsner, K. The neuroscience of empathy: Progress, pitfalls and promise. Nature Neuroscience 2012, 15(5), 675–680. [Google Scholar] [CrossRef]
- Damasio, A. Self comes to mind: Constructing the conscious brain; Pantheon, 2010. [Google Scholar]
- Damasio, A. R.; Carvalho, G. B. The nature of feelings: Evolutionary and neurobiological origins. Nature Reviews Neuroscience 2013, 14(2), 143–152. [Google Scholar] [CrossRef]
- Insel, T. R.; Young, L. J. The neurobiology of attachment. Nature Reviews Neuroscience 2001, 2(2), 129–136. [Google Scholar] [CrossRef] [PubMed]
- Koch, C. Consciousness: Confessions of a romantic reductionist; MIT Press, 2012. [Google Scholar]
- Kringelbach, M. L.; Berridge, K. C. The functional neuroanatomy of pleasure and happiness. Trends in Cognitive Sciences 2010, 14(7), 294–301. [Google Scholar]
- Lutz, A.; Slagter, H. A.; Dunne, J. D.; Davidson, R. J. Attention regulation and monitoring in meditation. Trends in Cognitive Sciences 2008, 12(4), 163–169. [Google Scholar] [CrossRef]
- Meyer-Lindenberg, A. Impact of prosocial genes on neural systems. Proceedings of the National Academy of Sciences 2008, 105(47), 18055–18056. [Google Scholar]
- Singer, T.; Klimecki, O. M. Empathy and compassion. Current Biology 2014, 24(18), R875–R878. [Google Scholar] [CrossRef]
- Varela, F. J. Neurophenomenology: A methodological remedy for the hard problem. Journal of Consciousness Studies 1996, 3(4), 330–349. [Google Scholar]
- Zimbardo, P. G. A situationist perspective on the psychology of evil: Understanding how good people are transformed into perpetrators. The Social Psychology of Good and Evil 2004, 21–50. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.